(FM) Inmunología
Departamento académico
University of Chicago
Chicago, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Chicago (5)
2024
-
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors
Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 3
2016
-
Perspectives in immunotherapy: Meeting report from the "Immunotherapy Bridge", Napoli, December 5th 2015
Journal for ImmunoTherapy of Cancer, Vol. 4, Núm. 1
2014
-
Classification of current anticancer immunotherapies
Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508
2012
2010
-
Clinical experiences with anti-CD137 and anti-PD1 therapeutic antibodies
Seminars in Oncology, Vol. 37, Núm. 5, pp. 508-516